Esther Kim
Family Medicine · Las Vegas, NVNPI 1023500352
Payments from drug & device makers
Across 126 payments — averaging $22.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$474
- Corcept Therapeutics$440
- Pfizer$280
- Lucid Diagnostics Inc.$261
- AstraZeneca$211
- Biohaven Pharmaceutical Holding Company Ltd.$178
- plus $952 from 15 others
Across 1 payment — averaging $500.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Lucid Diagnostics Inc.$500
What the payments were for
- Food & beverage$2,796100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 23 | $474 |
| Corcept Therapeutics | 15 | $440 |
| Pfizer | 15 | $280 |
| Lucid Diagnostics Inc. | 7 | $261 |
| AstraZeneca(2 entities) | 8 | $211 |
| Biohaven Pharmaceutical Holding Company Ltd. | 6 | $178 |
| Bayer | 5 | $171 |
| Lilly USA, LLC | 10 | $161 |
| Amgen(2 entities) | 8 | $148 |
| Optinose US, Inc. | 5 | $73 |
| Xeris Pharmaceuticals, Inc. | 3 | $61 |
| Mannkind Corporation | 3 | $59 |
| Daiichi Sankyo Inc. | 3 | $50 |
| Novartis | 3 | $48 |
| AbbVie | 3 | $48 |
| Exact Sciences | 3 | $42 |
| Organon | 2 | $30 |
| Boehringer Ingelheim | 1 | $18 |
| Dexcom, Inc. | 1 | $14 |
| C. R. Bard, Inc. & Subsidiaries | 1 | $14 |
| Scynexis, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NURTEC ODT$119
- Ozempic$114
- Kerendia$108
How this compares
$2,796 in reported general payments places this provider in the 80th percentile of 902 family medicine providers in Nevada.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Levothyroxine Sodium | 30 | $387 |
| Atorvastatin Calcium | 32 | $279 |
| Montelukast Sodium | 13 | $215 |
| Metformin Hcl ErMetformin Hcl | 12 | $208 |
| Lisinopril | 16 | $198 |
| Losartan Potassium | 12 | $150 |
| Alendronate Sodium | 11 | $137 |
| Hydrochlorothiazide | 21 | $132 |
| Donepezil Hcl | 13 | $118 |
| Citalopram HbrCitalopram Hydrobromide | 15 | $108 |
| Pravastatin Sodium | 11 | $85 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Las Vegas
- Rogelio MachucaLas Vegas$3.3M
- Maxine InghamLas Vegas$2.9M
- Elliot ShinLas Vegas$2.1M
- Robert KaplanLas Vegas$1.7M
- Sean SuLas Vegas$1.1M
- Naz WahabLas Vegas$735K
- Carmelo RilleraLas Vegas$531K
- Peter PhilanderLas Vegas$524K
- Jerry CadeLas Vegas$381K
- Dana ForteLas Vegas$169K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.